title: The cell type-specific IGF2 expression during early human development correlates to the pattern of overgrowth and neoplasia in the Beckwith-Wiedemann syndrome.
abstract: Overstimulation by insulin-like growth factor II is implied in several overgrowth conditions and childhood cancers. We have therefore studied spatial and temporal expression patterns of the insulin-like growth factor II gene (IGF2) and the insulin-like growth factor type 1 receptor gene during normal human development (5.5 to 23.0 weeks postfertilization). The set of cell types with the most abundant IGF2 expression correlated strikingly to the organomegaly and tumor predisposition of the Beckwith-Wiedemann syndrome. Intrauterine growth and postnatal organ weights of a prematurely born child with a full-blown syndrome are presented. The cell type-specific IGF2 expression of these organs and of multifocal Wilms' tumors from two other children affected by the Beckwith-Wiedemann syndrome were also studied. The results clarify and extend previous findings concerning human prenatal IGF2 expression and are consistent with a short range overstimulatory role of locally produced IGF II ensuing after the first trimester in the Beckwith-Wiedemann syndrome.
authors.affiliation: Department of Drug Dependence Research, Karolinska Hospital, Stockholm, Sweden.
authors.forename: F
authors.initials: F
authors.lastname: Hedborg
authors.forename: L
authors.initials: L
authors.lastname: Holmgren
authors.forename: B
authors.initials: B
authors.lastname: Sandstedt
authors.forename: R
authors.initials: R
authors.lastname: Ohlsson
mesh_terms: D001506:Beckwith-Wiedemann Syndrome / Q000196:embryology / Q000378:metabolism* / Q000473:pathology*; D005314:Embryonic and Fetal Development / Q000502:physiology*; D005333:Fetus / Q000166:cytology / Q000502:physiology*; D015870:Gene Expression; D006801:Humans; D007334:Insulin-Like Growth Factor I / Q000378:metabolism; D007335:Insulin-Like Growth Factor II / Q000235:genetics* / Q000378:metabolism; D017451:Receptors, Somatomedin / Q000378:metabolism
chemical_list: D017451:Receptors, Somatomedin; D007334:Insulin-Like Growth Factor I; D007335:Insulin-Like Growth Factor II